Cytosorbents Corp
CTSO
43 hedge funds and large institutions have $20.9M invested in Cytosorbents Corp in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
220% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 5
39% more funds holding
Funds holding: 31 → 43 (+12)
36% more capital invested
Capital invested by funds: $15.4M → $20.9M (+$5.46M)
2.31% more ownership
Funds ownership: 8.82% → 11.13% (+2.3%)
5% more call options, than puts
Call options by funds: $484K | Put options by funds: $462K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$1.43M |
| 2 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$971K |
| 3 |
Millennium Management
New York
|
+$781K |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$387K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$329K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$745K |
| 2 |
VF
Virtu Financial
New York
|
-$337K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$241K |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$117K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$35K |
CTSO Hedge Fund Activity: Q4 2017 in Review
43 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2017, worth a combined $20.9M — up 36% from $15.4M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CTSO positions and 5 closed out — a net gain of 12 holders — while 16 added to existing stakes and 5 trimmed.
The largest buyer was Skylands Capital, adding an estimated $1.43M. The largest seller was Susquehanna International Group, cutting an estimated $745K.
- 43 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2017, up from 31 in Q3 2017.
- Funds reported $20.9M of Cytosorbents Corp stock for Q4 2017, up 36% quarter-over-quarter.
- 17 funds opened new Cytosorbents Corp positions in Q4 2017 and 5 closed out, a net change of +12 holders.
- The largest Cytosorbents Corp buyer in Q4 2017 was Skylands Capital, an estimated $1.43M added.
- The largest Cytosorbents Corp seller in Q4 2017 was Susquehanna International Group, an estimated $745K sold.
Based on aggregated 13F filings for Q4 2017.